erlotinib hydrochloride has been researched along with bergamottin in 2 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (bergamottin) | Trials (bergamottin) | Recent Studies (post-2010) (bergamottin) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 104 | 6 | 51 |
| Protein | Taxonomy | erlotinib hydrochloride (IC50) | bergamottin (IC50) |
|---|---|---|---|
| Cytochrome P450 3A4 | Homo sapiens (human) | 2.42 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bart, AG; Scott, EE | 1 |
| Munro, AW | 1 |
2 other study(ies) available for erlotinib hydrochloride and bergamottin
| Article | Year |
|---|---|
Structures of human cytochrome P450 1A1 with bergamottin and erlotinib reveal active-site modifications for binding of diverse ligands.
Topics: Catalytic Domain; Crystallography, X-Ray; Cytochrome P-450 CYP1A1; Enzyme Assays; Enzyme Inhibitors; Erlotinib Hydrochloride; Furocoumarins; Humans; Ligands; Protein Binding; Substrate Specificity | 2018 |
Cytochrome P450 1A1 opens up to new substrates.
Topics: Catalytic Domain; Crystallography, X-Ray; Cytochrome P-450 CYP1A1; Enzyme Inhibitors; Erlotinib Hydrochloride; Furocoumarins; Humans; Ligands; Protein Binding; Substrate Specificity | 2018 |